White matter hyperintensities in patients with Parkinson's disease: A systematic review and meta-analysis
Authors:
- 1 July 2021
- journal article
- review article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 426, 117481
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Changes in Normal-Appearing White Matter Precede Development of White Matter LesionsStroke, 2013
- White Matter Hyperintensities in Parkinson’s Disease: Do They Explain the Disparity between the Postural Instability Gait Difficulty and Tremor Dominant Subtypes?PLOS ONE, 2013
- Pathology and pathogenesis of vascular cognitive impairment—a critical updateFrontiers in Aging Neuroscience, 2013
- Dopaminergic degeneration is enhanced by chronic brain hypoperfusion and inhibited by angiotensin receptor blockageAGE, 2012
- Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive statusJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's diseaseBrain, 2011
- The severity of leukoaraiosis correlates with the clinical phenotype of Parkinson’s diseaseArchives of Gerontology and Geriatrics, 2009
- A New Visual Rating Scale to Assess Strategic White Matter Hyperintensities Within Cholinergic Pathways in DementiaStroke, 2005
- A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CTStroke, 2001
- A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imagingJournal of the Neurological Sciences, 1993